Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
17.59
+0.99 (5.96%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $957.17 million as of December 20, 2024.
Market Cap
957.17M
Enterprise Value
436.86M
1-Year Change
n/a
Ranking
Category
Stock Price
17.59
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $957.17M, an increase of 2.73%. That is a compound annual growth rate of 10.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 957.17M | 2.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poseida Therapeutics | 917.16M |
| Gyre Therapeutics | 914.87M |
| Nuvation Bio | 905.36M |
| Replimune Group | 904.84M |
| Pacira BioSciences | 903.61M |
| Liquidia | 896.30M |
| Adaptive Biotechnologies | 885.48M |
| Phibro Animal Health | 883.38M |